Skip to content

Therapeutic Plasma Exchange in Thyrotoxicosis

Preoperative Therapeutic Plasma Exchange and Surgical Treatment in Thyrotoxicosis Patients: a Single-centre Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04485975
Enrollment
27
Registered
2020-07-24
Start date
1999-01-01
Completion date
2020-04-01
Last updated
2020-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyrotoxicosis

Brief summary

Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.

Detailed description

Background: Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis. Methods: The files of 27 patients who underwent preoperative TPE for thyrotoxicosis between January 1999 and February 2019 were retrospectively analyzed. The demographic and clinical features of the patients were included.

Interventions

Therapeutic plasma exchange filtrates plasma and decreases thyroid hormone concentration in the blood

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* thyrotoxicosis unresponsive to medication * adverse reaction to the medications * need for rapid treatment in patients that need urgent surgery

Exclusion criteria

* The patients who did not undergo surgery post-therapeutic plasma exchange * Preoperative hypocalcemia, * hemodynamically unstable patients * patients not suitable for central catheter placement

Design outcomes

Primary

MeasureTime frameDescription
Thyroid hormone levels of patients after therapeutic plasma exchange1 week before the operationConcentration of serum thyroid hormone levels before thyroidectomy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026